Evelyne Delfourne

Title: Evelyne Delfourne: Innovator in Antitumoral Pharmaceuticals

Introduction

Evelyne Delfourne is a notable inventor based in Pollestres, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with antitumoral properties. With a total of 2 patents, her work has the potential to impact cancer treatment significantly.

Latest Patents

Delfourne's latest patents include "Phenanthroline-7-one derivatives and their therapeutic uses," which describes a pharmaceutical composition that includes an efficient amount of a compound selected among specific formulae. These compounds exhibit interesting cytotoxic properties, leading to their therapeutic use as antitumoral medicines. Another patent, "Pharmaceutical composition based on polyaromatic compounds," outlines a composition comprising an efficient amount of a compound selected among various formulae, also demonstrating useful cytotoxic properties for therapeutic applications in antitumoral medicine.

Career Highlights

Throughout her career, Evelyne Delfourne has worked with reputable organizations, including Laboratoire L. Lafon. Her innovative research has positioned her as a key figure in the pharmaceutical industry, particularly in the development of new cancer treatments.

Collaborations

Delfourne has collaborated with notable professionals in her field, including Francis Darro and Jean Bastide. These collaborations have likely contributed to her success and the advancement of her research.

Conclusion

Evelyne Delfourne's contributions to pharmaceutical innovations, particularly in antitumoral medicines, highlight her role as a significant inventor in the industry. Her patents reflect her commitment to advancing cancer treatment through innovative research.